SCHEMBL19604258

SCHEMBL19604258

COCCc1ccccc1C(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
LMNA P02545 7/20 0.51
ALDH1A1 P00352 7/20 0.51
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 3/20 0.46
ADRB2 P07550 1/20 0.42
FOLH1 Q04609 1/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CTSD P07339 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13313177 0.88 LMNA (0.50) TSHRLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL13313199 0.86 LMNA (0.49) TSHRLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL8245934 0.85 FOLH1 (0.59) TSHRLMNAALDH1A1KDM4EFOLH1
SCHEMBL16445957 0.84 ALDH1A1 (0.68) TSHRLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL19291416 0.84 ALDH1A1 (0.46) TSHRLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL364447 0.84 TSHR (0.53) TSHRLMNAALDH1A1KDM4EFOLH1
SCHEMBL634451 0.82 TSHR (0.51) TSHRLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL3145722 0.81 LMNA (0.46) TSHRLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL14476991 0.81 LMNA (0.44) TSHRLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL19599266 0.81 TSHR (0.50) TSHRLMNAALDH1A1KDM4EADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170327490-A1 PIPERIDINE ISOXAZOLE AND ISOTHIAZOLE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327490-A1 PIPERIDINE ISOXAZOLE AND ISOTHIAZOLE OREXIN RECEPTOR ANTAGONISTS HCRTR2, HCRTR1, OXTR TSHR 211/4885LMNA 4521/4885ALDH1A1 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.